| Outcome Measures: |
Primary: Mean change in HbA1c, Mean change in HbA1c from baseline to Week 12, 12 Weeks | Secondary: Mean change in fasting plasma glucose, Mean change in fasting plasma glucose from baseline to Week 12, 12 Weeks|Proportion of patients achieving HbA1c <7.0%, Proportion of patients achieving HbA1c \<7.0% after 12 weeks of treatment, 12 Weeks|Proportion of patients achieving HbA1c <6.5%, Proportion of patients achieving HbA1c \<6.5% after 12 weeks of treatment, 12 Weeks|Mean change in postprandial glucose, Mean change in postprandial glucose from baseline to Week 12, 12 Weeks|Mean change in low-density lipoprotein cholesterol (LDL-C), Mean change in LDL-C from baseline to Week 12, 12 Weeks
|
| Locations: |
Peking University People's Hospital, Beijing, China|The Second Hospital of Jilin University, Chang chun, China|The First People's Hospital of Changde City, Changde, China|The Fourth Affiliated Hospital of Harbin Medical University, Harbin, China|Huizhou Municipal Central Hospital, Huizhou, China|Jinan Central Hospital, Jinan, China|Liaocheng People's Hospital, Liaocheng, China|The First Affiliated Hospital of Henan University of Science and Technology, Luoyang, China|Nanjing First Hospital, Nanjing, China|Nanjing Jiangning Hospital, Nanjing, China|Sir Run Run Hospital Nanjing Medical University, Nanjing, China|The First Affiliated Hospital of Nanyang Medical College, Nanyang, China|Yan'an University Affiliated Hospital, Yanan, China|Affiliated Hospital of Jiangsu University, Zhenjiang, China
|
